Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caffeine for Intermittent Hypoxia in Preterm Infants
NCT01875159Phase 3Completed
- Sponsor
- American SIDS Institute
- Start
- Jul 2010
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of caffeine in intermittent hypoxia (IH), sponsored by American SIDS Institute. Started Jul 2010; status: completed.
02
Drugs
caffeine
03
Conditions
intermittent hypoxia (IH)
Beyond the preview
Go deeper on NCT01875159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01875159.